ribociclib
eli lilly,novartis,pfizer
['natalee', '$nvs', '$pfe', '$lly']
first big #asco23 late-breaker: $nvs natalee trial yields hr=0.75. key detail revealed in wednesday's presser by dennis slamon: hr for node-negatives was 0.63... with a ci upper bound above 1.00 $lly $pfe 
Once had a blue tick. Journalist at Evaluate Vantage. Interested in: oncology, immunology. Not interested in: what stock you bought today.